Victory Capital Management
CDAK

Victory Capital Management’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Victory Capital Management’s Portfolio CDAK Stock Details CDAK Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
2022
Q4 		$27.5K Sell
2022
Q3 		$58K Sell
2022
Q2 		$214K Sell
2022
Q1 		$985K Sell
2021
Q4 		$2.35M Sell
2021
Q3 		$3.73M Sell
2021
Q2 		$4.27M Sell
2021
Q1 		$4.14M Buy
2020
Q4 		$3.05M Buy